Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Chinese Journal of Cardiology ; (12): 1001-1004, 2006.
Article in Chinese | WPRIM | ID: wpr-238459

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the relationship between thrombolysis in myocardial infarction (TIMI) risk score and efficacy of different treatment strategies in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS).</p><p><b>METHODS</b>From Oct. 2001 to Oct. 2003, 545 consecutive patients with NSTE-ACS were randomly assigned to early conservative strategy (n = 284) or early invasive strategy group (n = 261). The combined cardiovascular events (a combination of cardiac death, nonfatal myocardial infarction, nonfatal heart failure and re-hospital admission due to recurrent ischemia angina) within 30 days and 6 months were analyzed and related to the TIMI risk score at admission.</p><p><b>RESULTS</b>Rehospitalization due to recurrent ischemia angina of 30 days and the combined cardiovascular events of 30 days and 6 months were significantly lower in early invasive strategy group (3.5%, 10.0%, 21.1%) compared with early conservative strategy group (8.1%, 16.9%, 28.2%, all P < 0.05). Subgroup analysis indicated early invasive strategy could significantly decrease the 30 d incidence of the combined end point events in patients with high TIMI risk score and the 6 months incidence of the combined end point events in patients with moderate and high TIMI risk score (all P < 0.01), but the incidence was similar between the two different strategies in patients with low TIMI risk score.</p><p><b>CONCLUSIONS</b>Early invasive strategy may significantly reduce combined cardiovascular events in NSTE-ACS patients with moderate and high TIMI risk score compared with early conservative strategy.</p>


Subject(s)
Aged , Female , Humans , Male , Middle Aged , Angina, Unstable , Drug Therapy , Coronary Disease , Drug Therapy , Electrocardiography , Follow-Up Studies , Myocardial Infarction , Drug Therapy , Risk Assessment , Thrombolytic Therapy
SELECTION OF CITATIONS
SEARCH DETAIL